Skip to main content

Pharma

HIMSS24
By HIMSS TV | 05:12 pm | April 17, 2024
The founder and president of Medonations, a Lebanese medication company, talks about the aftermath of the 2020 Beirut explosion and her medication-access relief efforts following the disaster.  
By HIMSS TV | 07:00 am | April 15, 2024
European pharmacy experts, including leaders from Cleveland Clinic London and other organizations discuss Project Asclepius, a collaborative effort for digitizing pharmacy operations.  
By Trevor Dermody | 04:15 pm | March 15, 2024
The Israel-based company is the result of AION Labs' fifth startup challenge.
By Jessica Hagen | 01:53 pm | March 07, 2024
Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."
By Adam Ang | 01:11 am | February 26, 2024
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.   
By Jessica Hagen | 04:23 pm | February 23, 2024
The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.
By Jessica Hagen | 01:34 pm | February 08, 2024
The California-based company will put the funds toward its workforce, growing its data and further investing in R&D initiatives and engineering capabilities.
By HIMSS TV | 07:00 am | January 31, 2024
Ankit Gupta, Bicycle Health CEO and founder, discusses how the company helps formerly incarcerated individuals access buprenorphine monthly injections for opioid use disorder via the Federal Bureau of Prisons and residential reentry centers.  
By Nathan Eddy | 03:29 pm | January 29, 2024
One Medical providers will be able to request drug consultations on complex medication regimens for seniors managing chronic conditions.
By Jessica Hagen | 01:56 pm | January 11, 2024
The proposed class action lawsuit alleges the pharmacy benefit manager worked with rival PBMs to exert its influence in the market and fix reimbursement rates and fees.